glp-1 alzheimer's trial glp 1 trials near me Disappointing Results in Trial: Underscores Promise (and Limits) of Single-Agent Approaches Experts propose 10-year testing – GLP-1 drugs failed to slow

Allergic Reactions : Although rare, some people may experience allergic reactions

Check with your doctor immediately if any of the following side effects occur: Some side effects may occur that usually do not need medical attention

Investigating How GLP-1 May Contribute to Hair Loss Though not a direct side effect, a few mechanisms might explain how GLP-1 medications could indirectly contribute to hair loss

UHCs typical prior authorization requirements for Wegovy and Zepbound include: BMI documentation A documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea Comorbidity evidence Clinical records documenting the specific comorbidities that support the medical necessity of treatment Supervised weight management history Evidence of participation in a structured weight management program, which may include diet, exercise, and behavioral counseling, typically for 3 to 6 months prior to the request Prescriber qualifications The prescriber must be a physician, nurse practitioner, or physician assistant with appropriate prescribing authority UHC reviews prior authorizations against specific clinical policy bulletins